Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by 20g Processed Canola Protein 2 Drink Ingestion

Research Leaders

5 sponsors active, led by Maastricht University Medical Center

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT06058403Not ApplicableCompletedPrimary

Impact of Canola Protein Processing on Plasma Amino Acid Responses

NCT05446753Not ApplicableUnknown

Singapore Healthy Alternative Protein Evaluation Study

NCT03113279Completed

Mechanisms of Age-Related Muscle Loss

Showing all 3 trials

Research Network

Common Treatments

  • 20g Processed Canola Protein 2 Drink Ingestion1
  • Animalbased Meats1
  • 20g Native Canola Protein Drink Ingestion1
  • 20g Whey Protein Drink Ingestion1
  • Plantbased Meat Alternatives1

Active Sponsors

  • Maastricht University Medical Center1
  • DSM Food Specialties1
  • Prince September Pte. Ltd.1
  • Singapore Institute of Food and Biotechnology Innovation1
  • University of Birmingham1

Top Investigators

Related Conditions

  • Cardiovascular Diseases1
  • Sarcopenic Obesity1
  • Diabetes Mellitus1
  • Muscle Weakness1
  • Physical Activity1

Activity Timeline